Abstract:Wenjie Sun, 1, &ast Yeshan Li, 2, &ast Shuxin Tan 1 1 Graduate School, Wannan Medical College, Wuhu, Anhui, People's Republic of China; 2 Respiratory Department, The Second People's Hospital of Wuhu City, Wuhu, Anhui, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yeshan Li, Respiratory Department, The Second People's Hospital of Wuhu City, Wuhu, Anhui, 241000, People's Republic of China, Tel +8618055317993, Email Purpose: Patients with chronic obstructive pulmonary disease (COPD) often face unknown risks during acute exacerbation of the disease (AECOPD), which could potentially result in mortality. This study aimed to develop and validate a nomogram model for predicting the risk of in-hospital mortality in AECOPD patients. Patients and Methods: Clinical data of patients hospitalized at The Second People's Hospital of Wuhu City for AECOPD between January 2013 and December 2022 were retrospectively collected. Variables underwent selection through LASSO regression and multivariable logistic regression to develop a nomogram model. The model's predictive performance was assessed using the concordance index, calibration curve, and decision curve analysis (DCA), with internal validation conducted using the bootstrap method. Results: A total of 1224 patients were included in this study, with 98 (8%) deaths occurring during hospitalization. LASSO regression identified 11 variables, used to construct model A. Further multivariable logistic regression was conducted to select variables with P < 0.05 to establish model B. model B was selected as the final model based on discrimination, calibration, and clinical utility, encompassing variables including acute respiratory failure, lung cancer, heart rate, hemoglobin, absolute neutrophil count, serum albumin, blood urea nitrogen, and serum chloride. The nomogram model achieved a concordance index of 0.858. Internal validation of the model was conducted using the bootstrap method with 500 repetitions, resulting in a concordance index of 0.851 (95% CI: 0.805, 0.893). The calibration curve demonstrated a good fit, with a Hosmer-Lemeshow goodness-of-fit test P-value of 0.520. Moreover, DCA findings suggested patient benefit within a threshold probability range of 0.02 to 0.73, with a maximum net benefit of 0.07. Conclusion: The model constructed in this study has good predictive performance, which helps clinical doctors identify patients at high risk of death early. Keywords: acute exacerbation of chronic obstructive pulmonary disease, prediction model, nomogram Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition and has emerged as the third leading cause of death globally. 1 According to incomplete statistics, approximately 600 million individuals worldwide are affected by COPD, with millions of deaths attributed to the disease each year. 2 Factors such as smoking, environmental pollution, and population aging contribute to the increasing number of deaths associated with COPD, further burdening the treatment of this condition. 1 However, due to its inherent heterogeneity, the development of personalized treatment plans for COPD remains limited. Consequently, there is an urgent need to discover effective strategies for identifying high-risk patients with a propensity for mortality. With the development of molecular biology, research has discovered that certain biomarkers contribute to the prognosis evaluation of patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). For example, C-reactive protein (CRP), red cell distribution width (RDW), and N-terminal pro-brain natriuretic peptide (NT-proBNP). 3–5 However, the accuracy of these biomarkers in assessing the risk of mortality in AECOPD patients across different populations and disease severities appears to be inconsistent. For instance, Chen found that an elevated level of blood urea nitrogen (BUN) is associated with increased in-hospital mortality in AECOPD patients. 6 However, in the study by Li, 5 BUN was not identified as an independent risk factor for mortality in AECOPD patients. Such inconsistencies are common in research on multiple risk factors for mortality in AECOPD patients. Hence, relying solely on one clinical characteristic for evaluating the prognosis of AECOPD patients is unreliable. The use of a predictive model built on multiple risk factors enables the scoring of patients across different dimensions, where higher scores denote an elevated risk of in-hospital mortality. This approach enhances result reliability to a certain extent, providing a more intuitive and con -Abstract Truncated-

Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis—ABCD-10

Development and Validation of a Novel Score to Predict Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: CRISTEN

Systematic review and meta‐analysis of non‐SCORTEN predictors of mortality in Stevens‐Johnson syndrome and toxic epidermal necrolysis

A Multifactor Model for Predicting Mortality in Critically Ill Patients: A Multicenter Prospective Cohort Study

Models Predicting Mortality Risk of Patients with Burns to ≥ 50% of the Total Body Surface.

Evaluation of the Factors Influencing Mortality in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Study of 166 Patients

Establishment of Prognostic Scoring Models for Different Etiologies of Acute Decompensation in Hospitalized Patients with Cirrhosis

Clinico- Therapeutic Study of Stevens Johnson Syndrome-Toxic Epidermal Necrolysis and Prognostic Significance of SCORTEN in Indian Patients

Risk Prediction Model for In-Hospital Mortality in Women with ST-elevation Myocardial Infarction: A Machine Learning Approach

Development and Validation of a Sepsis Mortality Risk Score for Sepsis-3 Patients in Intensive Care Unit

Development and validation of a prediction model for mortality in critically ill COVID-19 patients

Development and validation of a prediction model for in-hospital mortality in patients with sepsis

Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results

45 Utility of the Severity-of-Illness Score for Toxic Epidermal Necrolysis (SCORTEN) in Pediatric Stevens-Johnson Syndrome Patients

Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience

Retrospective Study of 213 Cases of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis from China.

Development and Validation of a Survival Prediction Model for Patients with Pancreatic Cancer

Development of a Skin-Directed Scoring System for Stevens-Johnson Syndrome and Epidermal Necrolysis: A Delphi Consensus Exercise

Development and Validation of an In-Hospital Mortality Prediction Model for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Derivation and validation of a prognostic model to predict mortality in patients with advanced chronic kidney disease

Development and clinical empirical validation of the chronic critical illness prognosis prediction model